PATENT CLAIM ANALYSIS

Application Number: 16124974
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["544", "364000"]

Abstract:
A compound having formula IA is useful for treating a neurodegenerative disease: or a pharmaceutically acceptable salt or ester thereof, where R 0 , R 1 , R 2 , R 7 , R 8  are delineated substituents; A 1  is a C 6-12  aryl group, C 5-12  heteroaryl group, substituted 3-hydroxypyridin-4(1H)-one, with i hydrogen atoms replaced with R 7  and j hydrogen atoms replaced with R 8 ; p is an integer from 1 to 6; X 1 , Y 1  are each independently CH or N; M is absent or a divalent linking moiety in which Z is repeated m times; m is an integer from 0 to 5; i, j are each independently 0, 1, 2, or 3; and o is 0, 1, 2, 3, or 4.

Claim (Index 3):
The compound of  claim 1  wherein A 1  is:

Metadata:
- Claim Count in Document: 24.0
- Percentile: 97.0
- Lexical Diversity: 1.97436
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14648413', '13264505', '15187656', '14580045', '12588883']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8265434002573998
- 35 USC 102 Novelty (BERT): 0.5530505677460117
- Combined Prediction Score: 0.799194117006261
- Mean Citation Score: 378.093878
- Max Citation Score: 488.865
- Similarity Product: 290.02372459173205

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test